Rock Springs Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Rock Springs Capital Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-54,400	Closed	-$6.74M	–	137
2019 Q4	$6.74M	Hold	54,400	–	–	0.21%	98
2019 Q3	$3.61M	Buy	54,400 +4,400	+9%	+$295K	0.14%	117
2019 Q2	$3.98M	Buy	+50,000	New	+$4.48M	0.14%	114
2016 Q3	–	Sell	-10,000	Closed	-$1.43M	–	141
2016 Q2	$1.43M	Hold	10,000	–	–	0.11%	122
2016 Q1	$1.28M	Sell	10,000 -5,500	-35%	-$649K	0.11%	120
2015 Q4	$2.31M	Sell	15,500 -17,000	-52%	-$2.88M	0.18%	106
2015 Q3	$5.39M	Hold	32,500	–	–	0.44%	74
2015 Q2	$7.84M	Sell	32,500 -3,500	-10%	-$932K	0.57%	65
2015 Q1	$10.2M	Buy	36,000 +19,600	+120%	+$4.24M	0.95%	35
2014 Q4	$2.56M	Buy	16,400 +1,300	+9%	+$240K	0.3%	80
2014 Q3	$3.57M	Hold	15,100	–	–	0.55%	57
2014 Q2	$3.57M	Buy	15,100 +2,100	+16%	+$553K	0.64%	58
2014 Q1	$4.29M	Sell	13,000 -3,500	-21%	-$1.18M	0.99%	33
2013 Q4	$1.13M	Buy	+16,500	New	+$953K	0.4%	58

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Rock Springs Capital Management's ICPT Position: Q1 2020 in Review

Rock Springs Capital Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2020, closing a stake of 54,400 shares — an estimated $6.74M sold.

Rock Springs Capital Management first reported a position in ICPT in Q4 2013 and held it in 14 quarters. The position peaked at $10.2M in Q1 2015. 188 funds tracked by Wall St. Rank hold ICPT as of Q1 2020.

Rock Springs Capital Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Rock Springs Capital Management sold 54,400 Intercept Pharmaceuticals, Inc. shares in Q1 2020, an estimated $6.74M.
Rock Springs Capital Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2013 and held it in 14 quarters.
Rock Springs Capital Management's Intercept Pharmaceuticals, Inc. position peaked at $10.2M in Q1 2015.
188 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2020.

Based on Rock Springs Capital Management's 13F filing for Q1 2020, filed 15 May 2020.